We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GARP
3001
iShares MSCI USA Quality GARP ETF
GARP
$2.86B
$121K ﹤0.01%
4,252
-39,309
-90% -$1.09M
PVLA
3002
Palvella Therapeutics
PVLA
$2.23B
$121K ﹤0.01%
731
+600
+458% +$137K
FCCY
3003
DELISTED
1st Constitution Bancorp
FCCY
$121K ﹤0.01%
10,147
+8,261
+438% +$101K
DZSI
3004
DELISTED
DZS Inc. Common Stock
DZSI
$121K ﹤0.01%
12,935
+10,862
+524% +$109K
BELFB
3005
Bel Fuse Inc Class B
BELFB
$4.19B
$120K ﹤0.01%
11,259
+8,886
+374% +$101K
BEN icon
3006
Franklin Resources
BEN
$17.1B
$120K ﹤0.01%
5,886
-16,923
-74% -$355K
CCB icon
3007
Coastal Financial
CCB
$785M
$120K ﹤0.01%
9,829
+7,969
+428% +$110K
FSV icon
3008
FirstService
FSV
$6.15B
$120K ﹤0.01%
917
+794
+646% +$93.7K
HROW icon
3009
Harrow
HROW
$1.52B
$120K ﹤0.01%
21,385
+20,279
+1,834% +$122K
NTLA icon
3010
Intellia Therapeutics
NTLA
$1.65B
$120K ﹤0.01%
6,074
+2,468
+68% +$51.5K
ALPN
3011
DELISTED
Alpine Immune Sciences Inc
ALPN
$120K ﹤0.01%
13,645
+13,468
+7,609% +$123K
SMTX
3012
DELISTED
SMTC Corporation
SMTX
$120K ﹤0.01%
+33,367
New +$111K
AEG icon
3013
Aegon
AEG
$14B
$119K ﹤0.01%
50,616
-8,421
-14% -$22.4K
DAVA icon
3014
Endava
DAVA
$164M
$119K ﹤0.01%
+1,883
New +$102K
LQDA icon
3015
Liquidia Corp
LQDA
$6.78B
$119K ﹤0.01%
24,113
+20,436
+556% +$118K
RCUS icon
3016
Arcus Biosciences
RCUS
$3.64B
$119K ﹤0.01%
6,968
-13,651
-66% -$305K
XFOR icon
3017
X4 Pharmaceuticals
XFOR
$422M
$119K ﹤0.01%
586
+483
+469% +$116K
VIA
3018
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$119K ﹤0.01%
2,863
+2,431
+563% +$98.6K
MMP
3019
DELISTED
Magellan Midstream Partners, L.P.
MMP
$119K ﹤0.01%
3,488
+3,263
+1,450% +$129K
UMPQ
3020
DELISTED
Umpqua Holdings Corp
UMPQ
$119K ﹤0.01%
11,183
-30,914
-73% -$341K
FLNT
3021
Fluent
FLNT
$131M
$118K ﹤0.01%
7,916
+5,873
+287% +$85.2K
HBT icon
3022
HBT Financial
HBT
$1.35B
$118K ﹤0.01%
10,564
+8,569
+430% +$105K
HOOK
3023
DELISTED
HOOKIPA Pharma
HOOK
$118K ﹤0.01%
1,246
+440
+55% +$44.9K
KODK icon
3024
Kodak
KODK
$966M
$118K ﹤0.01%
13,411
+1,571
+13% +$12.3K
NERV icon
3025
Minerva Neurosciences
NERV
$216M
$118K ﹤0.01%
4,621
+3,763
+439% +$102K
119 120
121
122 123

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.